Oscar Health, Inc. (NYSE:OSCR) Receives $24.17 Consensus Target Price from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has received an average rating of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $24.17.

Several research analysts have commented on OSCR shares. Wells Fargo & Company upped their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Baird R W raised shares of Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Bank of America reaffirmed a “neutral” rating and set a $21.00 price objective (down from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Robert W. Baird assumed coverage on Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price on the stock. Finally, Piper Sandler restated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction on Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the transaction, the executive vice president now owns 392,607 shares in the company, valued at $6,697,875.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CFO Richard Scott Blackley sold 68,978 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the transaction, the chief financial officer now directly owns 884,213 shares in the company, valued at approximately $15,906,991.87. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. The disclosure for this sale can be found here. Over the last quarter, insiders sold 169,569 shares of company stock valued at $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

Institutional investors and hedge funds have recently modified their holdings of the business. Avalon Trust Co purchased a new stake in shares of Oscar Health during the first quarter valued at $69,000. Point72 Hong Kong Ltd bought a new stake in shares of Oscar Health in the second quarter worth approximately $78,000. Quest Partners LLC purchased a new position in shares of Oscar Health during the second quarter valued at approximately $93,000. Amalgamated Bank lifted its position in Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after purchasing an additional 1,458 shares during the period. Finally, Prevail Innovative Wealth Advisors LLC purchased a new stake in Oscar Health in the fourth quarter worth approximately $92,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Up 18.7 %

Shares of NYSE:OSCR opened at $20.67 on Monday. The stock’s 50-day moving average is $17.10 and its 200 day moving average is $17.27. The company has a market cap of $4.90 billion, a PE ratio of -51.68, a P/E/G ratio of 33.66 and a beta of 1.61. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. Oscar Health has a 1 year low of $4.72 and a 1 year high of $23.44.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the prior year, the company earned ($0.07) earnings per share. The firm’s revenue for the quarter was up 44.6% on a year-over-year basis. Sell-side analysts anticipate that Oscar Health will post 0.01 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.